Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Senetek PLC - SNTKY Breaks out to new high -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (717)	3/12/2002 7:01:08 PM
From: SemiBull	Read Replies (1) \| Respond to of 737

Senetek PLC Announces Investor Conference Call on March 15 NAPA, Calif., March 12 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - news), senetekplc.com , a biopharmaceutical company that develops products in two key markets, anti-aging and sexual dysfunction, today announced that its management will conduct its fourth quarter and year-end teleconference call for investors on Friday, March 15, 2002. The call will be available both by telephone and at a Webcast by CCBN. DATE: Friday, March 15, 2002 TIME: 1 p.m. Eastern Standard Time DIAL-IN: Domestic: 800/665-0430 International: 913/981-5591 CONFIRMATION CODE: 723212 REPLAY NUMBERS: Domestic: 888/203-1112 International: 719/457-0820 WEBCAST: CCBN's individual investor center at companyboardroom.com or at sites in CCBN's Individual Investor Network such as America Online's Personal Finance Channel. INSTITUTIONAL INVESTORS: Access the call using CCBN's password protected site Street Events ( streetevents.com ). CONTACT: Senetek Investor Relations, +1-707-226-3900, ext. 102 or Pknopick@eandecommunications.com. Senetek PLC, headquartered in Napa, California, is a science driven biopharmaceutical company engaged in the development of skincare/dermatological and sexual dysfunction products. Kinetin, the Company's patented anti-aging skincare technology, has been licensed to leading cosmetics and dermatological companies worldwide. Invicorp(TM) is Senetek's technology for the treatment of erectile dysfunction, a condition suffered by more than 100 million men worldwide. To learn more about Senetek, visit the Company's Website at senetekplc.com . SOURCE: Senetek PLC